China · Series D startup

Who invested in Biotheus

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$115Mraised across 2 rounds since 2019, from 2 sources

$15MSeed$100MSeries D
Latest round
Series D, $100MMar 2021
Step-upi
6.9×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20202021
$15MSeed$100MSeries D
First round
Seed, $15M
Jun 2019
Biggest round
$100M
Series D · Mar 2021
Between rounds
20 months
from the last two

The rounds

  1. Mar 2021
  2. Jun 2019
    Seed$15M1 new

    Reported by 36Kr

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

IDG CapitalPrivate equity1round
General AtlanticPrivate equity1round
Cowin CapitalVC firm1round
Highlight CapitalVC firm1round
Shiyu CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Biotheus

Who invested in Biotheus?

Biotheus's investors include IDG Capital, General Atlantic, Cowin Capital, Highlight Capital and Shiyu Capital.

How much has Biotheus raised?

Biotheus has raised $115M across 2 rounds since 2019.

When did Biotheus last raise?

Biotheus's most recent round was a Series D of $100M in Mar 2021.

What was Biotheus's biggest round?

Its most recent round, $100M in Mar 2021, is also its largest on record.

Who backed Biotheus first?

Biotheus's first round on record, in Jun 2019, was backed by Shiyu Capital.

What stage is Biotheus at?

Biotheus's latest named round is a Series D, in Mar 2021.

Where is Biotheus based?

Biotheus is based in China.

Companies like Biotheus

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.